阿司匹林联合依达拉奉对急性脑梗死患者血清Hcy的作用分析

doi:10.3969/j.issn.1006-6233.2019.09.018

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (1227 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective: To explore the effect of aspirin combined with edaravone on serum Hcy in patients with acute cerebral infarction. Methods: 70 patients with acute cerebral infarction who were treated in our hospital from March 2015 to December 2015 were selected as the research objects,the patients were divided into observation group (n=37) and control group (n=33) by random number table method. The control group was treated with aspirin, and the observation group was treated with edaravone on the basis of the control group. The clinical efficacy, serum Hcy, NIHSS score, modified Barthel index and the incidence of adverse reactions were compared between the two groups. Results: The total effective rate of the two groups was 94.59% and 69.70%, respectively (P < 0.05). After treatment, serum Hcy level in both groups was significantly decreased, and serum Hcy level in the observation group was significantly lower than that in the control group (P < 0.05). After treatment, NIHSS and improved Barthel index were significantly improved in both groups, and the improvement degree of NIHSS and improved Barthel index in the observation group was better than that in the control group (P < 0.05). The total incidence of adverse reactions in the two groups was 8.11% and 36.36%, with significant difference (P < 0.05). Conclusion:edaravone combined with aspirin in patients with acute cerebral infarction has a significant effect, which can improve the serum Hcy level of patients and improve the prognosis of patients with acute cerebral infarction, which is worthy of clinical promotion.

Key words： Edaravone Aspirin Acute cerebral infarction Homocysteine

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	KE Guangmin
	BAO Minqiang
	HU Renping

Cite this article:

KE Guangmin,BAO Minqiang,HU Renping. Effect Analysis of Aspirin Combined with Edaravone on Serum Hcy in Patients with Acute Cerebral Infarction[J]. HeBei Med, 2019, 25(9): 1477-1480.

URL:

http://www.hbyxzzs.cn/EN/10.3969/j.issn.1006-6233.2019.09.018 OR http://www.hbyxzzs.cn/EN/Y2019/V25/I9/1477

[1] 陈庆友,张艳蕉,于熙莹.丁苯酞联合依达拉奉治疗急性脑梗死的临床研究[J].中国临床药理学杂志,2016,32(16):1453~1455.
[2] 龚红英,李通.丁苯酞治疗急性脑梗死的临床研究[J].现代药物与临床,2017,32(1):51~54.
[3] 刘颖丽,杨立彬,张舒石,等.丁苯酞注射液治疗老年急性脑梗死患者的疗效及其对脑血流动力和脑血管储备能力的影响[J].吉林大学学报(医学版),2017,43(2):344~348.
[4] Wu W, Guan Y, Xu K, et al. Plasma homocysteine levels predict the risk of acute cerebral infarction in patients with carotid artery lesions[J]. Molecular Neurobiology, 2016, 53(4):2510~2517.
[5] 农媛,肖海,陈奎,等.尿激酶静脉溶栓治疗急性脑梗死的影响因素分析[J].中国实用神经疾病杂志,2017,20(20):30~33.
[6] 田自有,陈赛贞,徐利君,等.依达拉奉联合丹红注射液治疗急性脑梗死疗效的系统分析[J].中国实验方剂学杂志,2015,21(20):218~224.
[7] 高长玉,吴成翰,赵建国,等.中国脑梗死中西医结合诊治指南(2017)[J].中国中西医结合杂志,2018,38(2):136~144.
[8] Hori Y S, Kodera S, Sato Y, et al. Eosinopenia as a predictive factor of the short-term risk of mortality and infection after acute cerebral infarction[J]. Journal of Stroke & Cerebrovascular Diseases the Official Journal of National Stroke Association, 2016, 25(6):1307~1312.
[9] 高娟.阿司匹林联合氯吡格雷治疗急性脑梗死对患者认知功能的影响[J].解放军预防医学杂志,2018,36(9):1204~1206,1219.
[10] 许春奇,尚亚东,程仁力,等.氯吡格雷、阿司匹林和辛伐他汀联合首剂负荷量治疗老年急性脑梗死的效果[J].中国老年学杂志,2017,37(17):4247~4249.
[11] Saito T, Hayashi K, Nakazawa H, et al. Clinical Characteristics and Lesions Responsible for Swallowing Hesitation After Acute Cerebral Infarction[J]. Dysphagia, 2016, 31(4):567~573.
[12] 李平,汪波.依达拉奉联合溶栓治疗急性脑梗死的疗效及对氧自由基清除效果的影响[J].中国现代医学杂志,2015,25(28):49~52.
[13] 万长明.丁苯酞治疗急性脑梗死老年患者的疗效及对血清中S100B、Hcy和ANG-1的影响[J].东南大学学报(医学版),2015,34(1):79~82.